Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2018Frontiers in ImmunologyOpen Access

The Development of Serum Amyloid P as a Possible Therapeutic

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDarrell PillingTexas A&M UniversityRGRichard H. GomerTexas A&M University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pilling et al. (2018) studied this question.

synapsesocial.com/papers/6a1c3a78b33628da419d54ffhttps://doi.org/10.3389/fimmu.2018.02328
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum2000 · 67 citations
  2. 2Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts2009 · 506 citations
  3. 3Wound repair and regeneration: Mechanisms, signaling, and translation2014 · 3,588 citations